Spots Global Cancer Trial Database for advanced sarcoma
Every month we try and update this database with for advanced sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms | NCT00927966 | Sarcoma Solid Tumor | RAD001 CP-751,871 | 18 Years - | Dana-Farber Cancer Institute | |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | NCT05488366 | Sarcoma, Soft T... | Pembrolizumab Radiation thera... | 18 Years - | University of California, Irvine | |
| A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma | NCT06087341 | Advanced Sarcom... | NKG2D-CAR memor... | - 30 Years | Instituto de Investigación Hospital Universitario La Paz | |
| YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma | NCT05448820 | Advanced Sarcom... Metastatic Sarc... Soft Tissue Sar... | YH001 Envafolimab Doxorubicin | 18 Years - | Tracon Pharmaceuticals Inc. | |
| Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. | NCT03782363 | Sarcoma | Autologous CIK ... Autologous CIK ... Autologous CIK ... Autologous CIK ... | 10 Years - | Italian Sarcoma Group | |
| Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners | NCT03652298 | Colorectal Canc... Bladder Cancer Prostate Cancer Kidney Cancer Advanced Sarcom... | Memory structur... support and att... | 18 Years - | Centre Oscar Lambret | |
| Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. | NCT03782363 | Sarcoma | Autologous CIK ... Autologous CIK ... Autologous CIK ... Autologous CIK ... | 10 Years - | Italian Sarcoma Group | |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | NCT05488366 | Sarcoma, Soft T... | Pembrolizumab Radiation thera... | 18 Years - | University of California, Irvine | |
| Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas | NCT04242238 | Sarcoma Advanced Sarcom... High Grade Sarc... Leiomyosarcoma Undifferentiate... Myxofibrosarcom... Dedifferentiate... | DCC-3014 Avelumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| SMMART Adaptive Clinical Treatment (ACT) Trial | NCT05238831 | Advanced Breast... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Prosta... Advanced Sarcom... Anatomic Stage ... Anatomic Stage ... Recurrent Adult... Recurrent Breas... Recurrent Ovari... Recurrent Prost... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage IV Ovaria... Stage IV Pancre... | Alectinib Alpelisib Anastrozole Atezolizumab Bevacizumab Biopsy Biospecimen Col... Capecitabine Carboplatin Cobimetinib Entrectinib Eribulin Fulvestrant Hyaluronidase-z... Irinotecan Letrozole Nab-paclitaxel Niraparib Olaparib Paclitaxel Palbociclib Pertuzumab Quality-of-Life... Trastuzumab Trastuzumab Emt... Vemurafenib Vinorelbine Vismodegib | 18 Years - | OHSU Knight Cancer Institute | |
| Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas | NCT04242238 | Sarcoma Advanced Sarcom... High Grade Sarc... Leiomyosarcoma Undifferentiate... Myxofibrosarcom... Dedifferentiate... | DCC-3014 Avelumab | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
